Suven Life Sciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 6.61 | 4.94 | 6.67 |
| Operating Expense | 16.21 | 11.09 | 9.25 |
| Net Profit | -11.07 | -7.67 | -3.12 |
| Net Profit Margin | -167.47 | -155.26 | -46.78 |
| Earning Per Share | -0.51 | -0.35 | -0.14 |
| EBIDTA | -9.59 | -6.16 | -2.58 |
| Effective Tax Rate | TBA | TBA | 38.61 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 6.61 |
| Operating Expense | 16.21 |
| Net Profit | -11.07 |
| Net Profit Margin | -167.47 |
| Earning Per Share | -0.51 |
| EBIDTA | -9.59 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 11.69 | 13.54 | 11.84 |
| Operating Expenses Annual | 42.63 | 41.28 | 48.49 |
| Operating Profit Annual | -2.35 | -13.29 | -31.33 |
| Interest Annual | 0.16 | 0.29 | 0.53 |
| Depreciation | 6.47 | 6.52 | 4.37 |
| Net Profit Annual | -8.01 | -20.13 | -36.25 |
| Tax Annual | -1.00 | TBA | TBA |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 11.69 |
| Operating Expenses Annual | 42.63 |
| Operating Profit Annual | -2.35 |
| Interest Annual | 0.16 |
| Depreciation | 6.47 |
| Net Profit Annual | -8.01 |
| Tax Annual | -1.00 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 26.70 | 2.90 | 1.29 |
| Cash Flow from Operations | -20.56 | -22.92 | -36.62 |
| Cash Flow from Investing | -0.68 | -348.82 | -107.46 |
| Cash Flow from Financing | -1.05 | 395.54 | 145.69 |
| Cash Flow at the End | 4.40 | 26.70 | 2.90 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 26.70 |
| Cash Flow from Operations | -20.56 |
| Cash Flow from Investing | -0.68 |
| Cash Flow from Financing | -1.05 |
| Cash Flow at the End | 4.40 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | -122.16 | -154.87 | -297.38 |
| PBIT Margin (%) | -177.76 | -203.18 | -334.46 |
| PBT Margin (%) | 562.87 | 304.94 | 188.18 |
| Net PROFIT Margin (%) | -68.52 | -148.67 | -306.17 |
| Return On Networth / Equity (%) | -2.36 | -4.20 | -9.17 |
| Return On Networth /Employed (%) | -2.44 | -4.11 | -8.90 |
| Return On Assets (%) | -0.69 | -2.97 | -9.18 |
| Total Debt / Equity (X) | TBA | TBA | 0.01 |
| Asset Turnover Ratio (%) | 0.01 | 0.02 | 0.03 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | -122.16 |
| PBIT Margin (%) | -177.76 |
| PBT Margin (%) | 562.87 |
| Net PROFIT Margin (%) | -68.52 |
| Return On Networth / Equity (%) | -2.36 |
| Return On Networth /Employed (%) | -2.44 |
| Return On Assets (%) | -0.69 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.01 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 28.21 | 37.21 | 37.56 |
| Total Current Assets Annual | 246.14 | 241.26 | 64.22 |
| Non Current Assets Annual | 605.34 | 619.18 | 422.13 |
| Total Shareholders Funds Annual | 845.38 | 853.44 | 475.98 |
| Total Assets Annual | 851.48 | 860.44 | 486.35 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 28.21 |
| Total Current Assets Annual | 246.14 |
| Non Current Assets Annual | 605.34 |
| Total Shareholders Funds Annual | 845.38 |
| Total Assets Annual | 851.48 |
EPS (INR)
Expected
0.00
Reported
-2.27
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
